ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,554.25
-1.38%
Dow Jones
44,544.66
0.00%
Gold vs US Dollar
2,810.53
0.60%
Brent Oil
77.065
0.93%
Bitcoin
94,331.47
-3.45%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV

  6. Nurexone Biologic Inc (NRX) Share Price

NRX Nurexone Biologic Inc

0.63
0.00 (0.00%)
03 Feb 2025 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Nurexone Biologic Inc TSXV:NRX TSX Venture Exchange Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 0.63 0.61 0.64 0.00 0.00   12:49:17   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Miscellaneous Metal Ores,nec  -3.64M -0.0754 -8.36 30.4M
 Type  Size  Price  Time  Units 
   0.00  
 
Recent News
DateTimeSource
HeadlineMore NRX News
21/01/202521:20GLOBENurExone Secures C$1.2 Million through Warrant Exercises and Completion of Private Placement and Appoints New R&D Director
08/01/202521:12GLOBENurExone Biologic Secures Master Cell Bank
06/12/202421:03GLOBENurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage
27/11/202412:01GLOBENurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update
13/11/202421:14GLOBENurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
01/11/202420:50GLOBENurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update
23/10/202406:56GLOBENurExone’s Regenerative Medicine Therapies To Be Recognized at Fall Conferences in the USA
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
10/09/200907:58PBBNRX up on award of contract >>>>>>>>>>>>>>>>>>>>4
30/12/200216:31PBBWhy the sudden drop (50%) in NRX Global today ?8
20/11/200008:21PBBFii turning to NRX?1


Loading Follow Feed...

Latest Nurexone Biologic Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads